Matches in Nanopublications for { ?s ?p "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP59917.RAXux-0scuVko87aJ65MXZ7WGFxmlOlzbTaLiyKpICFCA130_assertion description "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59917.RAXux-0scuVko87aJ65MXZ7WGFxmlOlzbTaLiyKpICFCA130_provenance.
- NP229377.RAZBuOlWGuTvFHj201vgV-AgYAqHgh0IX0-Aq34Zajt6E130_assertion description "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229377.RAZBuOlWGuTvFHj201vgV-AgYAqHgh0IX0-Aq34Zajt6E130_provenance.
- NP79683.RAZY079fPypliP-TlTr6wwxYi-UK35rCHenymMMnjU-Rw130_assertion description "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79683.RAZY079fPypliP-TlTr6wwxYi-UK35rCHenymMMnjU-Rw130_provenance.
- NP393988.RAzUStZWEyLC_oBWcfEXJTXBEqVLhIBMmbk8Ql0PVKlvY130_assertion description "[Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393988.RAzUStZWEyLC_oBWcfEXJTXBEqVLhIBMmbk8Ql0PVKlvY130_provenance.